imc@healthandcommerce.com, Author at Corcept Therapeutics

About imc@healthandcommerce.com

This author has not written his bio yet.
But we are proud to say that imc@healthandcommerce.com contributed 159 entries already.

Entries by imc@healthandcommerce.com

Final Results of the CATALYST Trial

Dr. Katia Sloan • 2025 • ADCES

August 8, 2025

Characterization of Individuals With Difficult-to-Control Type 2 Diabetes and Post-Dexamethasone Suppression Test Cortisol Values <1.2, 1.2–1.8, and >1.8 μg/dL: Findings From the CATALYST Part 1 Study

Auchus et al. • 2025 • ENDO 2025

July 14, 2025

The Design of MOMENTUM: A Prospective Study of the Prevalence of Endogenous Hypercortisolism in Individuals With Resistant Hypertension

Einhorn et al. • 2025 • ENDO 2025

July 14, 2025

Effects of Relacorilant on Body Weight and Body Composition in Patients With Endogenous Hypercortisolism in the Phase 3 GRACE and GRADIENT Studies

Hamidi et al. • 2025 • ENDO 2025

July 13, 2025

Efficacy and Safety of Relacorilant in Individuals With Adrenal Hypercortisolism: Results From the Phase 3 GRACE and GRADIENT Studies

Badiu et al. • 2025 • ENDO 2025

July 13, 2025

Effects of Relacorilant on Pituitary Tumor Volume in Patients With Cushing Disease: Results From the Phase 3 GRACE Study

Dobri et al. • 2025 • International Pituitary Congress

July 10, 2025

Treatment of Hypercortisolism in People with Difficult-to-Control Type 2 Diabetes—Final Results of the CATALYST Trial

Pratley, DeFronzo, Aroda, Fonseca, Buse • 2025 • ADA

June 23, 2025

Comparative Effectiveness of Nab-Paclitaxel and Paclitaxel in Patients with Platinum-Resistant Ovarian Cancer (COMPASS)

Shahin et al. • 2025 • ESMO Gyn

June 20, 2025

Phase 3 Results of Relacorilant + Nab-Paclitaxel v Nab-Paclitaxel In Platinum-Resistant Ovarian Cancer (ROSELLA): Secondary Endpoints

Lorusso et al. • 2025 • ESMO Gyn

June 19, 2025

Impact of Relacorilant on Blood Pressure and Antihypertensive Medication Burden in Patients With Hypercortisolism and Hypertension: Results From the GRACE Study

Moraitis et al. • 2025 • Heart in Diabetes 2025

June 9, 2025